... <a href= Mind Cure Establishes Psychedelic Compound Research Program " />

Mind Cure Health will be focus its psychedelics R&D on psilocybin, ketamine and ibogaine. The Company will pursue both pain-based and mental health applications.

Mind Cure Establishes Psychedelic Compound Research Program " data-title="Tweet">
Mind Cure Establishes Psychedelic Compound Research Program " data-title="Share">
Mind Cure Establishes Psychedelic Compound Research Program " data-title="Pin">
Mind Cure Establishes Psychedelic Compound Research Program " data-title="Share">
Mind Cure Establishes Psychedelic Compound Research Program " data-title="+1">
MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )